Logo image
Sensitive detection of SARS-CoV-2 spike protein using vertically-oriented silicon nanowire array-based biosensor
Journal article   Open access   Peer reviewed

Sensitive detection of SARS-CoV-2 spike protein using vertically-oriented silicon nanowire array-based biosensor

Bingtao Gao, Anthony A Rojas Chavez, Walla I Malkawi, Daniel W Keefe, Rasheid Smith, Hillel Haim, Aliasger K Salem and Fatima Toor
Sensing and Bio-Sensing Research, Vol.36, pp.100487-100487
06/2022
DOI: 10.1016/j.sbsr.2022.100487
PMCID: PMC8937609
PMID: 35340912
url
https://doi.org/10.1016/j.sbsr.2022.100487View
Published (Version of record) Open Access

Abstract

The COVID-19 pandemic has caused tremendous damage to the world. In order to quickly and accurately diagnose the virus and contain the spread, there is a need for rapid, sensitive, accurate, and cost-effective SARS-CoV-2 biosensors. In this paper, we report on a novel biosensor based on angiotensin converting enzyme 2 (ACE-2)-conjugated vertically-oriented silicon nanowire (vSiNW) arrays that can detect the SARS-CoV-2 spike protein with high sensitivity and selectivity relative to negative controls. First, we demonstrate the efficacy of using ACE-2 receptor to detect the SARS-CoV-2 spike protein via a capture assay test, which confirms high specificity of ACE-2 against the mock protein, and high affinity between the spike and ACE-2. We then report on results for ACE-2-conjugated vSiNW arrays where the biosensor device architecture is based on a p-n junction transducer. We confirm via analytical modeling that the transduction mechanism of the biosensor involves induced surface charge depletion of the vSiNWs due to negative electrostatic surface potential induced by the spike protein after binding with ACE-2. This vSiNW surface charge modulation is measured via current-voltage characteristics of the functionalized biosensor. Calibrated concentration dependent electrical response of the vSiNW sensor confirms the limit-of-detection for virus spike concentration of 100 ng/ml (or 575 pM). The vSiNW sensor also exhibits highly specific response to the spike protein with respect to negative controls, offering a promising point-of-care detection method for SARS-CoV-2.
COVID-19 Label-free detection Metal-assisted chemical etching (MACE) Point-of-care device SARS-CoV-2 Silicon nanowire biosensor

Details

Metrics

Logo image